# Taxol Carboplatin and Erythropoetin

> **NCT00158379** · PHASE2 · COMPLETED · sponsor: **North Eastern German Society of Gynaecological Oncology** · enrollment: 105 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT00158379
- **Lead sponsor:** North Eastern German Society of Gynaecological Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2008-04
- **Final completion:** 2008-06
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2017-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00158379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00158379, "Taxol Carboplatin and Erythropoetin". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00158379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*